QuidelOrtho Statistics
Total Valuation
QuidelOrtho has a market cap or net worth of $1.53 billion. The enterprise value is $4.21 billion.
Important Dates
The last earnings date was Wednesday, February 11, 2026, after market close.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
QuidelOrtho has 68.08 million shares outstanding. The number of shares has increased by 0.89% in one year.
| Current Share Class | 68.08M |
| Shares Outstanding | 68.08M |
| Shares Change (YoY) | +0.89% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 115.91% |
| Float | 63.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.36 |
| PS Ratio | 0.56 |
| Forward PS | 0.55 |
| PB Ratio | 0.79 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.55 |
| P/OCF Ratio | 14.55 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 7.50, with an EV/FCF ratio of 40.06.
| EV / Earnings | n/a |
| EV / Sales | 1.54 |
| EV / EBITDA | 7.50 |
| EV / EBIT | 34.10 |
| EV / FCF | 40.06 |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 1.49.
| Current Ratio | 1.50 |
| Quick Ratio | 0.77 |
| Debt / Equity | 1.49 |
| Debt / EBITDA | 4.68 |
| Debt / FCF | 27.13 |
| Interest Coverage | 0.66 |
Financial Efficiency
Return on equity (ROE) is -46.15% and return on invested capital (ROIC) is 1.17%.
| Return on Equity (ROE) | -46.15% |
| Return on Assets (ROA) | 1.27% |
| Return on Invested Capital (ROIC) | 1.17% |
| Return on Capital Employed (ROCE) | 2.57% |
| Weighted Average Cost of Capital (WACC) | 6.26% |
| Revenue Per Employee | $413,667 |
| Profits Per Employee | -$171,485 |
| Employee Count | 6,600 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.61 |
Taxes
In the past 12 months, QuidelOrtho has paid $24.10 million in taxes.
| Income Tax | 24.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.34% in the last 52 weeks. The beta is 0.72, so QuidelOrtho's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -46.34% |
| 50-Day Moving Average | 29.07 |
| 200-Day Moving Average | 28.18 |
| Relative Strength Index (RSI) | 30.44 |
| Average Volume (20 Days) | 1,272,164 |
Short Selling Information
The latest short interest is 10.37 million, so 15.23% of the outstanding shares have been sold short.
| Short Interest | 10.37M |
| Short Previous Month | 10.52M |
| Short % of Shares Out | 15.23% |
| Short % of Float | 16.35% |
| Short Ratio (days to cover) | 10.39 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of $2.73 billion and -$1.13 billion in losses. Loss per share was -$16.69.
| Revenue | 2.73B |
| Gross Profit | 1.28B |
| Operating Income | 123.60M |
| Pretax Income | -1.11B |
| Net Income | -1.13B |
| EBITDA | 562.00M |
| EBIT | 123.60M |
| Loss Per Share | -$16.69 |
Full Income StatementBalance Sheet
The company has $170.10 million in cash and $2.85 billion in debt, with a net cash position of -$2.68 billion or -$39.42 per share.
| Cash & Cash Equivalents | 170.10M |
| Total Debt | 2.85B |
| Net Cash | -2.68B |
| Net Cash Per Share | -$39.42 |
| Equity (Book Value) | 1.92B |
| Book Value Per Share | 28.28 |
| Working Capital | 481.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $105.20 million and capital expenditures -$188.20 million, giving a free cash flow of $105.20 million.
| Operating Cash Flow | 105.20M |
| Capital Expenditures | -188.20M |
| Free Cash Flow | 105.20M |
| FCF Per Share | $1.55 |
Full Cash Flow StatementMargins
Gross margin is 46.81%, with operating and profit margins of 4.53% and -41.45%.
| Gross Margin | 46.81% |
| Operating Margin | 4.53% |
| Pretax Margin | -40.57% |
| Profit Margin | -41.45% |
| EBITDA Margin | 20.58% |
| EBIT Margin | 4.53% |
| FCF Margin | 3.85% |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.89% |
| Shareholder Yield | -0.89% |
| Earnings Yield | -73.95% |
| FCF Yield | 6.87% |
Analyst Forecast
The average price target for QuidelOrtho is $32.75, which is 45.69% higher than the current price. The consensus rating is "Hold".
| Price Target | $32.75 |
| Price Target Difference | 45.69% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
QuidelOrtho has an Altman Z-Score of 0.73 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.73 |
| Piotroski F-Score | 6 |
